Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: [Name Removed]
<[FOI #803609 email]> Sent: Tuesday, November 2,
2021 8:46:07 AM To: MHRA Customer Services Subject: Freedom of Information
request - Contaminants in the UK Covid experimental vaccines Dear
Medicines and Healthcare Products Regulatory Agency, I have just see the
following video:
https://eur01.safelinks.protection.outlo...
which shows pictures of contaminants in the UK Covid experimental
vaccines. Please provide images you hold and store in electronic format of
the content of the UK Government Covid experimental vaccines. Yours
faithfully, [Name Removed]
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #803609 email] Is [MHRA request email] the wrong
address for Freedom of Information requests to Medicines and Healthcare
Products Regulatory Agency? If so, please contact us using this form:
https://eur01.safelinks.protection.outlo...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

Our Ref: FOI 21/1180

Dear Gian A Ameri,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 2nd November 2021.

I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Please be aware that we publish FOIs replies and these are redacted and are located on our website at the following link below.
https://www.gov.uk/government/collection...

Kind Regards,

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000

show quoted sections

FOI 21/1180

Dear [Name Removed]

Thank you for your email.

Please find attached the response to your FOI request,

Yours sincerely

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000

show quoted sections

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: [Name Removed]
<[FOI #803609 email]> Sent: Monday, December 13,
2021 8:17:01 PM To: MHRA Customer Services Subject: Re: FOI 21/1180 - CSC
73464 Freedom of Information request - Contaminants in the UK Covid
experimental vaccines Dear MHRA Customer Services, your response is
misleading and incomplete (i.e. vague), thus I am seeking clarification.
1. Can you please clarify and state the total number of vials of the Covid
vaccines which you approve, but which have been reported as defective to
date? 2. Can you please clarify and state if any of the Covid vaccines
which you approve have to date completed the scheduled Stage 3 trials? 3.
Can you please clarify if routine independent batch testing of sample
vials is invasive (i.e. it involves testing of the actual content of the
vials) and, if so, who holds the related images and data, if not you?
Yours sincerely, [Name Removed] -----Original Message----- FOI 21/1180 Dear
[Name Removed] Thank you for your email. Please find attached the response
to your FOI request, Yours sincerely MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency 10 South Colonnade,
Canary Wharf, London E14 4PU Telephone 0203 080 6000
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #803609 email] Disclaimer: This message and
any reply that you make will be published on the internet. Our privacy and
copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

Dear [Name Removed]

Thank you for your email.

Please find below answers to the questions you have raised in blue below.

1. Can you please clarify and state the total number of vials of the Covid
vaccines which you approve, but which have been reported as defective to
date? Vaccines are only approved if they meet specification. Any batch
used in the UK vaccination programme has been certificated.

2. Can you please clarify and state if any of the Covid vaccines which you
approve have to date completed the scheduled Stage 3 trials? For all
clinical trials that are conducted, the main efficacy and safety results
for the Phase I, II and III trials have been submitted to MHRA, sufficient
that these vaccines can be authorised for use in the patient populations
stated in the Information for Healthcare Professionals/Summary of Product
Characteristics for each vaccine. These studies are currently ongoing to
follow-up vaccine recipients to collect additional safety data, in the
same way that all clinical trials for new medicines follow up their study
subjects after the main results of the study have been reported.

3. Can you please clarify if routine independent batch testing of sample
vials is invasive (i.e. it involves testing of the actual content of the
vials) and, if so,  who holds the related images and data, if not you? We
have already responded about visual inspection and it is not an invasive
test.

Yours sincerely

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

Telephone 0203 080 6000

show quoted sections